Cargando…

Observational study on the safety profile of gadoterate meglumine in 35,499 patients: The SECURE study

PURPOSE: To investigate the safety of gadoterate meglumine and identify the incidence of nephrogenic systemic fibrosis (NSF). MATERIALS AND METHODS: An international prospective observational study was conducted from November 2008 to June 2013. A total of 35,499 adults and children who were schedule...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soyer, Philippe, Dohan, Anthony, Patkar, Deepak, Gottschalk, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585792/ https://www.ncbi.nlm.nih.gov/pubmed/27726239 http://dx.doi.org/10.1002/jmri.25486

Ejemplares similares

Safety of gadoterate meglumine in over 1600 children included in the prospective observational SECURE study
por: Chang, De-Hua, et al.
Publicado: (2019)

A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years
por: Scala, Mario, et al.
Publicado: (2018)

Anaphylaxis to gadobutrol and gadoterate meglumine in a patient with low grade astrocytoma
por: Montalvo, Juan Manuel Escobar, et al.
Publicado: (2014)

Gadoterate meglumine decreases ADC values of breast lesions depending on the b value combination
por: Arponen, Otso, et al.
Publicado: (2018)

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)
por: Deray, Gilbert, et al.
Publicado: (2012)

Comprehensive Speciation Analysis of Residual Gadolinium in Deep Cerebellar Nuclei in Rats Repeatedly Administered With Gadoterate Meglumine or Gadodiamide
por: Strzeminska, Izabela, et al.
Publicado: (2022)

Safety of Gadoterate Meglumine (Gd-DOTA) as a Contrast Agent for Magnetic Resonance Imaging: Results of a Post-Marketing Surveillance Study in Japan
por: Ishiguchi, Tsuneo, et al.
Publicado: (2012)

Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats
por: Bussi, Simona, et al.
Publicado: (2021)

Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model
por: Wang, Shu-ting, et al.
Publicado: (2019)

Respiratory anomalies associated with gadoxetate disodium and gadoterate meglumine: compressed sensing MRI revealing physiologic phenomena during the entire injection cycle
por: Glessgen, Carl Guillaume, et al.
Publicado: (2021)

Lack of evidence of a relationship between magnetic resonance signal intensity changes in the globus pallidus and dentate nucleus, and repeated administrations of gadoterate meglumine in children
por: Lancelot, Eric, et al.
Publicado: (2017)

Single-Dose Gadoterate Meglumine for 3T Late Gadolinium Enhancement MRI for the Assessment of Chronic Myocardial Infarction: Intra-Individual Comparison with Conventional Double-Dose 1.5T MRI
por: Lim, Jiyeon, et al.
Publicado: (2018)

Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging
por: Krug, Kathrin Barbara, et al.
Publicado: (2021)

The Pattern of Use, Effectiveness, and Safety of Gadoteric Acid (Clariscan) in Patients Undergoing Contrast-Enhanced Magnetic Resonance Imaging: A Prospective, Multicenter, Observational Study
por: Moon, Won-Jin, et al.
Publicado: (2021)

Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018)

Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients
por: Raynaud, Jean-Sébastien, et al.
Publicado: (2018)

Comparison of Intralesional Meglumine Antimonite along with oral Itraconazole to Intralesional Meglumine Antimonite in the treatment of Cutaneous Leishmaniasis
por: Bashir, Uzma, et al.
Publicado: (2019)

Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats
por: Fretellier, Nathalie, et al.
Publicado: (2019)

Incidental Intrathecal Injection of Meglumine Diatrizoate
por: Masjedi, Mansour, et al.
Publicado: (2014)

FIRST REPORT ON OTOTOXICITY OF MEGLUMINE ANTIMONIATE
por: Valete-Rosalino, Cláudia Maria, et al.
Publicado: (2014)

Tafamidis and tafamidis meglumine for amyloid cardiomyopathy
Publicado: (2021)

Poster Sessions 499–563
Publicado: (2001)

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
por: Vargas, Deninson Alejandro, et al.
Publicado: (2019)

Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate
por: Guarneri, Claudio, et al.
Publicado: (2017)

Cancer of the Anal Canal: Diagnosis, Staging and Follow-Up with MRI
por: Durot, Carole, et al.
Publicado: (2017)

The Role of Magnetic Resonance Imaging in the Management of Esophageal Cancer
por: Pellat, Anna, et al.
Publicado: (2022)

Elevated miR-499 Levels Blunt the Cardiac Stress Response
por: Shieh, Joseph T. C., et al.
Publicado: (2011)

Preliminary study on the effects of enrofloxacin, flunixin meglumine and pegbovigrastim on Mycoplasma bovis pneumonia
por: Dudek, Katarzyna, et al.
Publicado: (2019)

499 Visiting Scholars in Times of Pandemic
por: Moussatche, Patricia, et al.
Publicado: (2022)

MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid
por: Collettini, Federico, et al.
Publicado: (2022)

Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke: A Randomized Clinical Trial
por: Zhang, Qian, et al.
Publicado: (2023)

Transdermal Flunixin Meglumine as a Pain Relief in Donkeys: A Pharmacokinetics Pilot Study
por: McLean, Amy K., et al.
Publicado: (2023)

SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019)

Management of a case of accidental intrathecal administration of meglumine diatrizoate
por: Chirumamilla, Vikramaditya, et al.
Publicado: (2012)

P499 A cross-sectional observational to assess the role of Bronchoalveolar lavage fluid galactomannan in the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients
por: Nomula, Gowtham Reddy, et al.
Publicado: (2022)

Effects of flunixin meglumine on experimental tendon wound healing: A histopathological and mechanical study in rabbits
por: Behfar, Mehdi, et al.
Publicado: (2013)

Analgesic Comparison of Flunixin Meglumine or Meloxicam for Soft-Tissue Surgery in Sheep: A Pilot Study
por: Viscardi, Abbie V., et al.
Publicado: (2021)

SAT499 Amyloid Goiter: A Case Series
por: Paz-Ibarra, Jose, et al.
Publicado: (2023)

Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran
por: Aflatoonian, Mohammad Reza, et al.
Publicado: (2019)

A polymorphism rs3746444 within the pre‐miR‐499 alters the maturation of miR‐499‐5p and its antiapoptotic function
por: Ding, Wei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3vie3i3f8g3kaj5h4v1glh34md